MONITORING BOUNDARIES FOR ADVERSE-EFFECTS IN LONG-TERM CLINICAL-TRIALS

被引：13

作者：

LAN, KKG ^{[1
]}

FRIEDMAN, L ^{[1
]}

机构：

[1] NHLBI,BETHESDA,MD 20205

来源：

CONTROLLED CLINICAL TRIALS | 1986年 / 7卷 / 01期

关键词：

D O I：

10.1016/0197-2456(86)90002-4

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

引用

页码：1 / 7

页数：7

共 21 条

[1] [Anonymous], 1978, BR HEART J, V40, P1069
[2] [Anonymous], 1982, JAMA, V248, P1465
[3] REPEATED SIGNIFICANCE TESTS ON ACCUMULATING DATA
ARMITAGE, P
MCPHERSO.CK
ROWE, BC
[J]. JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES A-GENERAL, 1969, 132 : 235 - &
[4] MONITORING LONG-TERM CLINICAL-TRIALS FOR BENEFICIAL AND ADVERSE TREATMENT EFFECTS
CANNER, PL
[J]. COMMUNICATIONS IN STATISTICS-THEORY AND METHODS, 1984, 13 (19) : 2369 - 2394
[5] STATISTICAL ASPECTS OF EARLY TERMINATION IN THE BETA-BLOCKER HEART ATTACK TRIAL
DEMETS, DL
HARDY, R
FRIEDMAN, LM
LAN, KKG
[J]. CONTROLLED CLINICAL TRIALS, 1984, 5 (04): : 362 - 372
[6] DEMETS DL, 1982, BIOMETRIKA, V69, P661
[7] DEMETS DL, 1980, BIOMETRIKA, V67, P651
[8] Friedman Lawrence, 1981, IRB, V3, P6, DOI 10.2307/3563613
[9] Lan KG, 1982, COMMUN STATIST C, P37, DOI DOI 10.1080/07474948208836014
[10] DISCRETE SEQUENTIAL BOUNDARIES FOR CLINICAL-TRIALS
LAN, KKG
DEMETS, DL
[J]. BIOMETRIKA, 1983, 70 (03) : 659 - 663